Calisagan, Liezel .

HRN: 19-62-70  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2026
CEFUROXIME 500MG (TAB)
06/15/2026
06/22/2026
PO
500mg
BID
RMLE
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines